The effects of suplatast tosilate (IPD-1151T) on innate immunity and antigen-presenting cells

Transplant Immunology

Volumn 18, Issue 2, 2007, Pages 108-114

  Hsu, Li Wen ^a,c   Yang, Chin Hsiang ^a   Goto, Shigeru ^a,b   Nakano, Toshiaki ^a   Lai, Chia Yun ^a   Lin, Yu Chun ^a   Kao, Ying Hsien ^a   Chen, Shu Hui ^c   Cheng, Yu Fan ^a,d   Jawan, Bruno ^a,d   Chiu, King Wah ^a,d   Tsao, Fu Kai ^e   Chen, Chao Long ^a,d  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b Iwao Hospital   (Japan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antigen presenting cells; Dendritic cells; Suplatast tosilate; T helper cytokines; Toll like receptor

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; PEPTIDOGLYCAN; SUPLATAST TOSYLATE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; DRUG MECHANISM; HEART TRANSPLANTATION; HELPER CELL; HETEROTOPIC TRANSPLANTATION; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD14; ARYLSULFONATES; CONCANAVALIN A; DENDRITIC CELLS; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; RATS; RNA, MESSENGER; SULFONIUM COMPOUNDS; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS; TOLL-LIKE RECEPTORS;

EID: 36048944463     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2007.05.008     Document Type: Article

References (21)

1. Yamaya H., Basaki Y., Togawa M., Kojima M., Kiniwa M., and Matsuura N. Down-regulation of Th2 cell-mediated murine peritoneal eosinophilia by antiallergic agents. Life Sci 56 19 (1995) 1647-1654
2. Yanagihara Y., Kiniwa M., Ikizawa K., Shida T., Matsuura N., and Koda A. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (2). Regulation of human IgE response. Jpn J Pharmacol 61 1 (1993) 31-39
3. Yanagihara Y., Kiniwa M., Ikizawa K., et al. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (1). Regulation of murine IgE response. Jpn J Pharmacol 61 1 (1993) 23-30
4. Hsu L.W., Goto S., Lin Y.C., et al. Prolongation of heart allograft survival of rats treated by a Th2 inhibitor. Transpl Immunol 11 3-4 (2003) 385-388
5. Leung T.F., Tang N.L., Wong G.W., and Fok T.F. CD14 and toll-like receptors: potential contribution of genetic factors and mechanisms to inflammation and allergy. Curr Drug Targets Inflamm Allergy 4 2 (2005) 169-175
6. Feleszko W., Jaworska J., and Hamelmann E. Toll-like receptors-novel targets in allergic airway disease (probiotics, friends and relatives). Eur J Pharmacol 533 1-3 (2006) 308-318
7. Robinson D.S., and O'Garra A. Further checkpoints in Th1 development. Immunity 16 6 (2002) 755-758
8. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 1 2 (2001) 135-145
9. Dabbagh K., and Lewis D.B. Toll-like receptors and T-helper-1/T-helper-2 responses. Curr Opin Infect Dis 16 3 (2003) 199-204
10. Farina C., Theil D., Semlinger B., Hohlfeld R., and Meinl E. Distinct responses of monocytes to Toll-like receptor ligands and inflammatory cytokines. Int Immunol 16 6 (2004) 799-809
11. Prebeck S., Kirschning C., Durr S., et al. Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae -induced activation of dendritic cells. J Immunol 167 6 (2001) 3316-3323
12. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 6673 (1998) 245-252
13. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu Rev Immunol 20 (2002) 197-216
14. Hsu L.W., Goto S., Nakano T., et al. The effects of anti-histone H1 antibody on immune cells responsible for rejection reaction. Mol Immunol 42 10 (2005) 1155-1164
15. Iwashita Y., Tahara K., Goto S., et al. A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer. Cancer Immunol Immunother 52 3 (2003) 155-161
16. Medzhitov R., and Janeway Jr. C. Innate immunity. N Engl J Med 343 5 (2000) 338-344
17. Tsoulfas G., Takahashi Y., Ganster R.W., et al. Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury. Transplantation 74 1 (2002) 7-13
18. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2 8 (2001) 675-680
19. Goldstein D.R. Toll-like receptors and other links between innate and acquired alloimmunity. Curr Opin Immunol 16 5 (2004) 538-544
20. Eisenbarth S.C., Piggott D.A., Huleatt J.W., Visintin I., Herrick C.A., and Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 196 12 (2002) 1645-1651
21. Redecke V., Hacker H., Datta S.K., et al. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 172 5 (2004) 2739-2743